ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Halozyme Therapeutics Incorporated

Halozyme Therapeutics Incorporated (HALO)

47.79
-0.04
( -0.08% )
Updated: 14:22:06

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 181.5M162.14M221.04M216.03M230.04M195.88M231.35M290.08M
Operating Income 74.51M53.8M94.46M88.28M101.04M95.54M117.24M163.2M
Pre Tax Income 70.79M52.24M93.16M101.76M101.18M96.03M117.74M165.15M
Net Income 57.7M39.62M74.75M81.84M85.39M76.82M93.25M137.01M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 74.51M53.8M94.46M88.28M101.04M95.54M117.24M163.2M
EBITDA 81.62M74.26M115.09M111.36M121.73M115.75M137.57M183.56M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 146.69M316.61M151.86M195.99M267.59M443.31M660.12M829.25M
Operating Income -83.21M81M-69.33M-67.61M144.26M275.9M267.53M337.57M
Pre Tax Income -101.86M61.61M-79.79M-72.25M129.3M248.52M248.92M348.33M
Net Income -103.02M62.97M-80.33M-72.24M129.09M402.71M202.13M281.59M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.7480.417-0.525-0.4990.9012.7641.412.007
EBIT -83.21M81M-61.75M-60.62M149.68M254.94M264.82M337.57M
EBITDA -80.8M83.16M-66.94M-63.54M147.54M278.9M317.17M422.43M

Your Recent History

Delayed Upgrade Clock